News Articles Tagged: Cardiometabolic Risk

The Impact of Canagliflozin on Cardiovascular Health in Type 2 Diabetes Patients

Investigate the significant role of Canagliflozin in reducing cardiovascular risk in type 2 diabetes patients, alongside its glycemic control benefits. Insights from NINGBO INNO PHARMCHEM CO.,LTD.

Clinical Efficacy of Mazdutide: Real-World Data and Future Prospects

Examine the clinical efficacy of Mazdutide through real-world data and clinical trial outcomes. Understand its potential in combating obesity and metabolic diseases, with insights from NINGBO INNO PHARMCHEM CO.,LTD.